ALX Oncology Holdings Inc
General ticker "ALXO" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $83.0M
ALX Oncology Holdings Inc does not follow the US Stock Market performance with the rate: -36.4%.
Estimated limits based on current volatility of 8.9%: low 1.56$, high 1.87$
Factors to consider:
- Current price 76.9% below estimated low
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [8.09$, 20.34$]
- 2024-12-30 to 2025-12-30 estimated range: [5.87$, 15.44$]
Financial Metrics affecting the ALXO estimates:
- Negative: Non-GAAP EPS, $ of -3.59 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -21.11 <= 2.35
- Negative: negative Net income
- Positive: Interest expense per share, $ of 0.04 <= 0.14
- Negative: -0.39 < Industry inventory ratio change (median), % of 0
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
Short-term ALXO quotes
Long-term ALXO plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $83.56MM | $127.44MM | $170.28MM |
| Operating Income | $-83.56MM | $-127.44MM | $-170.28MM |
| Non-Operating Income | $0.07MM | $4.02MM | $9.47MM |
| Interest Expense | $0.01MM | $0.00MM | $1.56MM |
| R&D Expense | $60.17MM | $98.40MM | $141.79MM |
| Income(Loss) | $-83.48MM | $-123.42MM | $-160.81MM |
| Taxes | $-0.02MM | $0.06MM | $0.00MM |
| Profit(Loss) | $-83.46MM | $-123.48MM | $-160.81MM |
| Stockholders Equity | $363.05MM | $263.46MM | $189.71MM |
| Inventory | $0.00MM | $17.70MM | $0.00MM |
| Assets | $380.18MM | $306.49MM | $242.55MM |
| Operating Cash Flow | $-68.10MM | $-89.22MM | $-130.36MM |
| Capital expenditure | $4.92MM | $1.43MM | $1.27MM |
| Investing Cash Flow | $-4.92MM | $-235.42MM | $44.66MM |
| Financing Cash Flow | $2.47MM | $9.86MM | $59.29MM |
| Earnings Per Share* | $-2.07 | $-3.03 | $-3.74 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.